Checkpoint Therapeutics CFO Sells Shares to Cover Tax Obligations
| Reporter Name | Gray William Garrett |
| Relationship | Chief Financial Officer |
| Type | Sell |
| Amount | $1,076,412 |
| SEC Filing | Form 4 |
Checkpoint Therapeutics' Chief Financial Officer, William Garrett Gray, sold 268,432 shares of common stock on December 18, 2024, at a weighted average price of $4.01 per share, totaling $1,076,412. This sale was conducted to satisfy tax withholding obligations related to the vesting of 629,000 shares, with no discretion on the part of Mr. Gray. Following this transaction, Gray directly owns 1,032,754 shares of Checkpoint Therapeutics' common stock, including restricted stock that vests over time.
SEC Filing: Checkpoint Therapeutics, Inc. [ CKPT ] - Form 4 - Dec. 20, 2024